Key result
Chronic hemodialysis is linked to reduced early vascular aging after 5 years in ESRD.
Why the study?
Early vascular aging (EVA) in end-stage renal disease (ESRD) patients and its association with ESRD etiology and hemodialysis over time was not well characterized.
Cohort (n=434)
Answers are grounded in this paper and cite their sources.
May support arterial stiffness monitoring during hemodialysis in ESRD; leaves open whether this alters events or differs by etiology.
AIMS: To analyze the early vascular aging (EVA) in end-stage renal disease (ESRD) patients, attempting to determine a potential association between EVA and the etiology of ESRD, and to investigate the association of hemodialysis and EVA in ESRD patients during a 5-year follow-up period. METHODS: Carotid-femoral pulse wave velocity (cfPWV) was obtained in 151 chronically hemodialyzed patients (CHP) and 283 control subjects, and in 25 CHP, who were followed-up after a 5-year lapse. RESULTS: cfPWV increased in ESRD patients compared to control subjects. The cfPWV-age relationship was found to have a steeper increase in ESRD patients. The highest cfPWV and EVA values were observed in patients with diabetic nephropathy. Regression analysis demonstrated a significant reduction of the EVA in HD patients on a 5-year follow-up. CONCLUSION: Patients in ESRD showed higher levels of EVA. cfPWV and EVA differed in ESRD patients depending on their renal failure etiology. CHP showed an EVA reduction after a 5-year follow-up period.
No takes yet. Share an insight, caveat, or question.
Bia et al. (2016) conducted a cohort in End-stage renal disease (ESRD) (n=434). Hemodialysis vs. Control subjects was evaluated on Early vascular aging (EVA) and Carotid-femoral pulse wave velocity (cfPWV). Patients with end-stage renal disease showed higher levels of early vascular aging compared to controls, but chronically hemodialyzed patients exhibited a significant reduction after 5 years.
Synapse has enriched 10 related papers. Consider them for comparative context: